Skip to main content
Erschienen in: Odontology 1/2022

16.08.2021 | Original Article

WDR5 promotes the tumorigenesis of oral squamous cell carcinoma via CARM1/β-catenin axis

verfasst von: Xiao-Ying Lyu, Yu-Sen Shui, Liang Wang, Qing-Song Jiang, Ling-Xi Meng, Hao-Yuan Zhan, Ran Yang

Erschienen in: Odontology | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Oral squamous cell carcinoma (OSCC) is a malignancy all over the world. WD repeat domain 5 (WDR5) is involved in cancer progression. In addition, it was reported that WDR5 is upregulated in head and neck cancer, while its role in OSCC is unknown. First, the expression of WDR5 in oral cancer tissues and cells was examined by qRT-PCR, IHF and western blot. CCK-8 assay was performed to test the cell viability. Cell migration was assessed by transwell assay. Knocking down WDR5 or CARM1 in oral cancer cells to detect its function on cancer growth, WDR5 and CARM1 were significantly upregulated in OSCC. Silencing WDR5 suppressed OSCC cell viability and migration. CARM1 level in OSCC cells was significantly inhibited by WDR5 downregulation, and CARM1 elevation could rescue the effect of WDR5 knockdown on tumorigenesis of OSCC. Moreover, silencing of WDR5 notably inactivated β-catenin signaling pathway, while this phenomenon was restored by CARM1 overexpression. Silencing of WDR5 attenuated the tumorigenesis of OSCC via CARM1/β-catenin axis. Thus, WDR5 might be a target for OSCC treatment.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wang X, et al. ZFAS1 promotes cisplatin resistance via suppressing miR-421 expression in oral squamous cell carcinoma. Cancer Manag Res. 2020;12:7251–62.CrossRefPubMedPubMedCentral Wang X, et al. ZFAS1 promotes cisplatin resistance via suppressing miR-421 expression in oral squamous cell carcinoma. Cancer Manag Res. 2020;12:7251–62.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Liu J, et al. The circ-AMOTL1/ENO1 axis implicated in the tumorigenesis of OLP-associated oral squamous cell carcinoma. Cancer Manag Res. 2020;12:7219–30.CrossRefPubMedPubMedCentral Liu J, et al. The circ-AMOTL1/ENO1 axis implicated in the tumorigenesis of OLP-associated oral squamous cell carcinoma. Cancer Manag Res. 2020;12:7219–30.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Yao Y, et al. LncRNA JPX overexpressed in oral squamous cell carcinoma drives malignancy via miR-944/CDH2 axis. Oral Dis. 2020;27(4):924–33. Yao Y, et al. LncRNA JPX overexpressed in oral squamous cell carcinoma drives malignancy via miR-944/CDH2 axis. Oral Dis. 2020;27(4):924–33.
5.
Zurück zum Zitat Yu L, et al. Long non-coding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) promotes cell proliferation and migration by regulating miR-143-3p and MAGE family member A9 (MAGEA9) in oral squamous cell carcinoma. Med Sci Monit. 2020;26:e924187.PubMedPubMedCentral Yu L, et al. Long non-coding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) promotes cell proliferation and migration by regulating miR-143-3p and MAGE family member A9 (MAGEA9) in oral squamous cell carcinoma. Med Sci Monit. 2020;26:e924187.PubMedPubMedCentral
6.
Zurück zum Zitat Teratani M, et al. Antitumor effects and tumor-specificity of guaiazulene-3-carboxylate derivatives against oral squamous cell carcinoma in vitro. Anticancer Res. 2020;40(9):4885–94.CrossRefPubMed Teratani M, et al. Antitumor effects and tumor-specificity of guaiazulene-3-carboxylate derivatives against oral squamous cell carcinoma in vitro. Anticancer Res. 2020;40(9):4885–94.CrossRefPubMed
8.
Zurück zum Zitat Krishna A, et al. Upregulated histone deacetylase 2 gene correlates with the progression of oral squamous cell carcinoma. Cancer Biomark. 2020;29(4):543-52 Krishna A, et al. Upregulated histone deacetylase 2 gene correlates with the progression of oral squamous cell carcinoma. Cancer Biomark. 2020;29(4):543-52
9.
Zurück zum Zitat Zhang C, et al. LncRNA ANRIL acts as a modular scaffold of WDR5 and HDAC3 complexes and promotes alteration of the vascular smooth muscle cell phenotype. Cell Death Dis. 2020;11(6):435.CrossRefPubMedPubMedCentral Zhang C, et al. LncRNA ANRIL acts as a modular scaffold of WDR5 and HDAC3 complexes and promotes alteration of the vascular smooth muscle cell phenotype. Cell Death Dis. 2020;11(6):435.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Shen C, et al. ALKBH4 functions as a suppressor of colorectal cancer metastasis via competitively binding to WDR5. Front Cell Dev Biol. 2020;8:293.CrossRefPubMedPubMedCentral Shen C, et al. ALKBH4 functions as a suppressor of colorectal cancer metastasis via competitively binding to WDR5. Front Cell Dev Biol. 2020;8:293.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Dai B, et al. WD repeat domain 5 promotes invasion, metastasis and tumor growth in glioma through up-regulated zinc finger E-box binding homeobox 1 expression. Cancer Manag Res. 2020;12:3223–35.CrossRefPubMedPubMedCentral Dai B, et al. WD repeat domain 5 promotes invasion, metastasis and tumor growth in glioma through up-regulated zinc finger E-box binding homeobox 1 expression. Cancer Manag Res. 2020;12:3223–35.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Wu Y, et al. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma. J Oral Pathol Med. 2018;47(5):502–10.CrossRefPubMed Wu Y, et al. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma. J Oral Pathol Med. 2018;47(5):502–10.CrossRefPubMed
13.
Zurück zum Zitat Wang F, et al. WDR5-Myc axis promotes the progression of glioblastoma and neuroblastoma by transcriptional activating CARM1. Biochem Biophys Res Commun. 2020;523(3):699–706.CrossRefPubMed Wang F, et al. WDR5-Myc axis promotes the progression of glioblastoma and neuroblastoma by transcriptional activating CARM1. Biochem Biophys Res Commun. 2020;523(3):699–706.CrossRefPubMed
14.
Zurück zum Zitat Guo N, et al. MiR-542-5p regulates the progression of diabetic retinopathy by targeting CARM1. Acta Biochim Pol. 2020;67(3):373-8 Guo N, et al. MiR-542-5p regulates the progression of diabetic retinopathy by targeting CARM1. Acta Biochim Pol. 2020;67(3):373-8
15.
Zurück zum Zitat Cao Q, et al. MicroRNA-184 negatively regulates corneal epithelial wound healing via targeting CDC25A, CARM1, and LASP1. Eye Vis (Lond). 2020;7:35.CrossRef Cao Q, et al. MicroRNA-184 negatively regulates corneal epithelial wound healing via targeting CDC25A, CARM1, and LASP1. Eye Vis (Lond). 2020;7:35.CrossRef
16.
Zurück zum Zitat Veazey KJ, et al. CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas. Leukemia. 2020;34(12):3269-85 Veazey KJ, et al. CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas. Leukemia. 2020;34(12):3269-85
17.
Zurück zum Zitat Moena D, et al. Switches in histone modifications epigenetically control vitamin D3-dependent transcriptional upregulation of the CYP24A1 gene in osteoblastic cells. J Cell Physiol. 2020;235(6):5328–39.CrossRefPubMed Moena D, et al. Switches in histone modifications epigenetically control vitamin D3-dependent transcriptional upregulation of the CYP24A1 gene in osteoblastic cells. J Cell Physiol. 2020;235(6):5328–39.CrossRefPubMed
18.
Zurück zum Zitat Wu D, et al. CARM1 promotes non-small cell lung cancer progression through upregulating CCNE2 expression. Aging (Albany NY). 2020;12(11):10578–93.CrossRef Wu D, et al. CARM1 promotes non-small cell lung cancer progression through upregulating CCNE2 expression. Aging (Albany NY). 2020;12(11):10578–93.CrossRef
19.
Zurück zum Zitat Liu J, et al. Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer. EMBO Rep. 2020;21(2):e48597.PubMed Liu J, et al. Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer. EMBO Rep. 2020;21(2):e48597.PubMed
20.
Zurück zum Zitat Fioravanti R, et al. Properly substituted cyclic Bis-(2-bromobenzylidene) compounds behaved as dual p300/CARM1 inhibitors and induced apoptosis in cancer cells. Molecules. 2020;25(14). Fioravanti R, et al. Properly substituted cyclic Bis-(2-bromobenzylidene) compounds behaved as dual p300/CARM1 inhibitors and induced apoptosis in cancer cells. Molecules. 2020;25(14).
23.
Zurück zum Zitat Li N, et al. Long non-coding RNA ADAMTS9-AS1 suppresses colorectal cancer by inhibiting the Wnt/beta-catenin signalling pathway and is a potential diagnostic biomarker. J Cell Mol Med. 2020;24(19):11318–29 Li N, et al. Long non-coding RNA ADAMTS9-AS1 suppresses colorectal cancer by inhibiting the Wnt/beta-catenin signalling pathway and is a potential diagnostic biomarker. J Cell Mol Med. 2020;24(19):11318–29
24.
Zurück zum Zitat Yu X, et al. SNHG1 represses the anti-cancer roles of baicalein in cervical cancer through regulating miR-3127-5p/FZD4/Wnt/beta-catenin signaling. Exp Biol Med (Maywood). 2020;246(1):20-30 Yu X, et al. SNHG1 represses the anti-cancer roles of baicalein in cervical cancer through regulating miR-3127-5p/FZD4/Wnt/beta-catenin signaling. Exp Biol Med (Maywood). 2020;246(1):20-30
25.
Zurück zum Zitat Wei Z, et al. miR-223 regulates oral squamous cell carcinoma metastasis through the Wnt/beta-catenin signaling pathway. Oral Oncol. 2020;109:104941.CrossRefPubMed Wei Z, et al. miR-223 regulates oral squamous cell carcinoma metastasis through the Wnt/beta-catenin signaling pathway. Oral Oncol. 2020;109:104941.CrossRefPubMed
26.
Zurück zum Zitat Ou CY, et al. A coactivator role of CARM1 in the dysregulation of beta-catenin activity in colorectal cancer cell growth and gene expression. Mol Cancer Res. 2011;9(5):660–70.CrossRefPubMedPubMedCentral Ou CY, et al. A coactivator role of CARM1 in the dysregulation of beta-catenin activity in colorectal cancer cell growth and gene expression. Mol Cancer Res. 2011;9(5):660–70.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Xie X, et al. Diverse CBX family members as potential prognostic biomarkers in non small cell lung cancer. FEBS Open Bio. 2020; doi:10.23736/S0031-0808.20.03978-6 Xie X, et al. Diverse CBX family members as potential prognostic biomarkers in non small cell lung cancer. FEBS Open Bio. 2020; doi:10.23736/S0031-0808.20.03978-6
28.
Zurück zum Zitat Grzywa-Celinska A, et al. A single-institution retrospective analysis of the differences between 7th and 8th edition of the UICC TNM staging system in patients with advanced lung cancer. Eur Rev Med Pharmacol Sci. 2020;24(16):8394–401.PubMed Grzywa-Celinska A, et al. A single-institution retrospective analysis of the differences between 7th and 8th edition of the UICC TNM staging system in patients with advanced lung cancer. Eur Rev Med Pharmacol Sci. 2020;24(16):8394–401.PubMed
29.
Zurück zum Zitat Lin LH, et al. Targeting UDP-glucose dehydrogenase inhibits ovarian cancer growth and metastasis. J Cell Mol Med. 2020;24(20):11883-902 Lin LH, et al. Targeting UDP-glucose dehydrogenase inhibits ovarian cancer growth and metastasis. J Cell Mol Med. 2020;24(20):11883-902
30.
Zurück zum Zitat Camorani S, et al. Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer. J Exp Clin Cancer Res. 2020;39(1):180.CrossRefPubMedPubMedCentral Camorani S, et al. Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer. J Exp Clin Cancer Res. 2020;39(1):180.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Hu B, et al. High expression of CARM1 inhibits lung cancer progression by targeting TP53 by regulating CTNNB1. Lung. 2020;198(2):415–22.CrossRefPubMed Hu B, et al. High expression of CARM1 inhibits lung cancer progression by targeting TP53 by regulating CTNNB1. Lung. 2020;198(2):415–22.CrossRefPubMed
33.
Zurück zum Zitat Sharma P, Bhattacharyya DK, Kalita J. Disease biomarker identification from gene network modules for metastasized breast cancer. Sci Rep. 2017;7(1):1072.CrossRefPubMedPubMedCentral Sharma P, Bhattacharyya DK, Kalita J. Disease biomarker identification from gene network modules for metastasized breast cancer. Sci Rep. 2017;7(1):1072.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Gao Z, et al. Knockdown of lncRNA ZNRD1-AS1 inhibits progression of bladder cancer by regulating miR-194 and H3K4me3. Cancer Med. 2020;9(20):7695-705 Gao Z, et al. Knockdown of lncRNA ZNRD1-AS1 inhibits progression of bladder cancer by regulating miR-194 and H3K4me3. Cancer Med. 2020;9(20):7695-705
35.
Zurück zum Zitat Wang T, et al. The Calcium pump PMCA4 prevents epithelial-mesenchymal transition by inhibiting NFATc1-ZEB1 pathway in gastric cancer. Biochim Biophys Acta Mol Cell Res. 2020;1867(12):118833 Wang T, et al. The Calcium pump PMCA4 prevents epithelial-mesenchymal transition by inhibiting NFATc1-ZEB1 pathway in gastric cancer. Biochim Biophys Acta Mol Cell Res. 2020;1867(12):118833
36.
Zurück zum Zitat Kumar S, et al. CARM1 inhibition enables immunotherapy of resistant tumors by dual action on tumor cells and T cells. Cancer Discov. 2021;11(8):2050–71 Kumar S, et al. CARM1 inhibition enables immunotherapy of resistant tumors by dual action on tumor cells and T cells. Cancer Discov. 2021;11(8):2050–71
38.
Zurück zum Zitat Dulay RM, et al. Cytotoxicity of Gymnopilus purpureosquamulosus extracts on hematologic malignant cells through activation of the SAPK/JNK signaling pathway. PLoS ONE. 2021;16(5):e0252541.CrossRefPubMedPubMedCentral Dulay RM, et al. Cytotoxicity of Gymnopilus purpureosquamulosus extracts on hematologic malignant cells through activation of the SAPK/JNK signaling pathway. PLoS ONE. 2021;16(5):e0252541.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Kleszcz R, et al. Inhibition of CBP/beta-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells. Cell Oncol (Dordr). 2019;42(4):505–20.CrossRef Kleszcz R, et al. Inhibition of CBP/beta-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells. Cell Oncol (Dordr). 2019;42(4):505–20.CrossRef
41.
Zurück zum Zitat Li S, et al. The overexpression of CARM1 promotes human osteosarcoma cell proliferation through the pGSK3beta/beta-catenin/cyclinD1 signaling pathway. Int J Biol Sci. 2017;13(8):976–84.CrossRefPubMedPubMedCentral Li S, et al. The overexpression of CARM1 promotes human osteosarcoma cell proliferation through the pGSK3beta/beta-catenin/cyclinD1 signaling pathway. Int J Biol Sci. 2017;13(8):976–84.CrossRefPubMedPubMedCentral
42.
Metadaten
Titel
WDR5 promotes the tumorigenesis of oral squamous cell carcinoma via CARM1/β-catenin axis
verfasst von
Xiao-Ying Lyu
Yu-Sen Shui
Liang Wang
Qing-Song Jiang
Ling-Xi Meng
Hao-Yuan Zhan
Ran Yang
Publikationsdatum
16.08.2021
Verlag
Springer Singapore
Erschienen in
Odontology / Ausgabe 1/2022
Print ISSN: 1618-1247
Elektronische ISSN: 1618-1255
DOI
https://doi.org/10.1007/s10266-021-00649-6

Weitere Artikel der Ausgabe 1/2022

Odontology 1/2022 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Zahnmedizin

Bestellen Sie unseren kostenlosen Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.